サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1655419

神経血管ステントの世界市場

Neurovascular Stents

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
神経血管ステントの世界市場
出版日: 2025年02月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

神経血管ステントの世界市場は2030年までに34億米ドルに達する見込み

2024年に19億米ドルと推定される神経血管ステントの世界市場は、2024年から2030年にかけてCAGR 9.7%で成長し、2030年には34億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである頸動脈ステントは、CAGR 10.3%を記録し、分析期間終了時には25億米ドルに達すると予測されます。頭蓋内ステントセグメントの成長率は、分析期間中CAGR 8.0%と推定されます。

米国市場は推定5億4,870万米ドル、中国はCAGR9.0％で成長予測

米国の神経血管ステント市場は、2024年に5億4,870万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR 9.0％を牽引し、2030年には5億1,150万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.7%と7.8%と予測されています。欧州では、ドイツがCAGR約7.7%で成長すると予測されています。

世界の神経血管ステント市場- 主要動向と促進要因まとめ

神経血管ステントとは何か、なぜ脳卒中管理に不可欠なのか？

神経血管ステントは、脳血管障害の治療、特に虚血性脳卒中や動脈瘤の予防・治療に使用される特殊器具です。これらの小さなメッシュ状のチューブは、動脈を開いた状態に保ったり、動脈瘤から血流を遠ざけたりするために、脳の血管内に留置されます。血栓が脳への血流を阻害する虚血性脳卒中の場合、血行を回復させ、脳の永続的な損傷を防ぐために、神経血管ステントが使用されることが多いです。動脈瘤の場合、流れを変えるステントは、弱くなった血管壁から血液を遠ざけ、破裂のリスクを減らす効果的な方法を提供します。

神経血管ステントは、より侵襲的でリスクの高い処置が必要とされる疾患に対して、低侵襲的な治療を可能にするため、極めて重要です。ステントが動脈壁を支え、手技中および手技後の崩壊を防ぐ能力は、その有効性にとって極めて重要です。これらのステントの使用は、患者の転帰を改善し、回復時間を短縮し、脳卒中再発や動脈瘤破裂のリスクを大幅に減少させることで、脳卒中管理に革命をもたらしています。

神経血管ステント市場はどのように進歩しているのか？

神経血管ステント市場は、より洗練された特殊なステントデザインの開発により、急速に進歩しています。重要な動向のひとつは、複雑で頚部の広い動脈瘤の治療に普及しつつある、流れを変えるステントの台頭です。従来のステントとは異なり、フローダイバーターは動脈瘤から血流を迂回させることで機能し、時間の経過とともに血管が治癒することを可能にします。この技術革新により、複数回の手術の必要性が減少し、かつては手術不可能と考えられていた動脈瘤に対して、より安全な選択肢を提供することができます。

もうひとつの大きな進歩は、自己拡張型ステントの開発です。このステントは、患者の血管の独特な形状に適合するように設計されています。これらのステントは、より精密に展開することができ、動脈に外傷を与える可能性も低いです。さらに、目的を果たすと徐々に溶解する生体吸収性ステントが人気を集めています。これらのステントは永続的移植に伴う長期的リスクを軽減し、若年患者や従来の金属ステントによる合併症のリスクが高い患者には特に有益です。

どのような疾患が神経血管ステントの採用を促進しているのでしょうか？

神経血管ステントの採用は、主に虚血性脳卒中と脳動脈瘤の治療の必要性によって推進されています。血栓が脳への血流を阻害する虚血性脳卒中では、ステントリトリーバーが血行を回復させ、長期的な障害や死亡を防ぐために重要です。これらの装置により、血栓を機械的に除去し、閉塞した動脈を再開通させることができ、患者の転帰を大幅に改善することができます。神経血管ステントは、頸動脈狭窄症の治療にも使用されます。頸動脈狭窄症は、頸動脈が狭くなって脳への血流を制限し、脳卒中のリスクを高める疾患です。

脳動脈瘤は、ステント採用を促進するもう一つの重要な疾患です。血流転換ステントは、従来のコイリング技術では治療が困難な頸部の広い動脈瘤や大きな動脈瘤の治療に使用されます。これらのステントは、動脈瘤破裂のリスクを低減し、時間の経過とともに血管の治癒を可能にする低侵襲のソリューションを提供します。さらに、神経血管ステントは動静脈奇形（AVM）などの血管奇形の治療にも使用されており、神経学での用途がさらに拡大しています。

神経血管ステント市場の主な成長促進要因は？

神経血管ステント市場の成長は、いくつかの要因によってもたらされます。特に高齢化社会における虚血性脳卒中や脳動脈瘤の発生率の増加が、需要の主な原動力となっています。さらに、低侵襲治療への嗜好の高まりが、従来の手術よりも安全で迅速かつ効果的な治療選択肢を提供するとして、神経血管ステントの採用を後押ししています。流路転換技術や生体吸収性材料などのステント設計における技術革新も、これらのデバイスの安全性と有効性を向上させることで市場の成長を後押ししています。

脳卒中予防に対する意識の高まりと早期介入のメリットは、脳卒中関連死亡率を低下させる政府の取り組みとともに、市場をさらに押し上げています。さらに、医療画像やリアルタイムナビゲーション技術の進歩により、神経血管ステント治療の精度が高まり、患者の転帰が向上しています。新興国市場におけるヘルスケアインフラの拡大も、高度な神経血管治療へのアクセスを増加させることで市場の成長に寄与しています。

セグメント

製品タイプ（頸動脈ステント、頭蓋内ステント）、エンドユーザー（病院、外来手術センター）

調査対象企業の例（注目の11社）

  • Abbott Laboratories
  • ACANDIS GmbH
  • Blockade Medical LLC
  • Cordis Corporation
  • InspireMD, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • STI Laser Industries, Ltd.
  • Stryker Corporation
  • Terumo Medical Corporation
  • W. L. Gore & Associates

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13585

Global Neurovascular Stents Market to Reach US$3.4 Billion by 2030

The global market for Neurovascular Stents estimated at US$1.9 Billion in the year 2024, is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 9.7% over the analysis period 2024-2030. Carotid Artery Stents, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Intracranial Stents segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$548.7 Million While China is Forecast to Grow at 9.0% CAGR

The Neurovascular Stents market in the U.S. is estimated at US$548.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$511.5 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Neurovascular Stents Market - Key Trends & Drivers Summarized

What Are Neurovascular Stents and Why Are They Crucial in Stroke Management?

Neurovascular stents are specialized devices used to treat cerebrovascular conditions, particularly in the prevention and treatment of ischemic strokes and aneurysms. These small, mesh-like tubes are implanted in blood vessels in the brain to help keep arteries open or to redirect blood flow away from aneurysms. In cases of ischemic stroke, where blood clots block the flow of blood to the brain, neurovascular stents are often deployed to restore circulation and prevent permanent brain damage. For aneurysms, flow-diverting stents offer an effective way to redirect blood away from weakened vessel walls, reducing the risk of rupture.

Neurovascular stents are vital because they enable minimally invasive treatments for conditions that would otherwise require more invasive and higher-risk procedures. Their ability to support the artery walls and prevent collapse during and after the procedure is critical to their effectiveness. The use of these stents has revolutionized stroke management by improving patient outcomes, reducing recovery times, and significantly decreasing the risk of recurrent strokes or aneurysm ruptures.

How Is the Neurovascular Stents Market Advancing?

The neurovascular stents market is advancing quickly due to the development of more sophisticated and specialized stent designs. One of the key trends is the rise of flow-diverting stents, which are becoming increasingly popular for treating complex and wide-necked aneurysms. Unlike traditional stents, flow-diverters work by diverting blood flow away from the aneurysm, allowing the vessel to heal over time. This innovation reduces the need for multiple procedures and offers a safer alternative for aneurysms that were once considered inoperable.

Another significant advancement is in the development of self-expanding stents, which are designed to conform to the unique shape of the patient’s blood vessel. These stents can be deployed with greater precision and are less likely to cause trauma to the artery. Moreover, bioresorbable stents, which gradually dissolve after serving their purpose, are gaining traction. These stents reduce the long-term risks associated with permanent implants and are particularly beneficial in younger patients or those at higher risk for complications from traditional metal stents.

Which Conditions Are Driving the Adoption of Neurovascular Stents?

The adoption of neurovascular stents is primarily driven by the need to treat ischemic strokes and brain aneurysms. In ischemic strokes, where a blood clot obstructs blood flow to the brain, stent retrievers are critical in restoring circulation and preventing long-term disability or death. These devices allow for the mechanical removal of the clot and the reopening of the blocked artery, significantly improving patient outcomes. Neurovascular stents are also used in the treatment of carotid artery stenosis, a condition in which the carotid arteries narrow and restrict blood flow to the brain, increasing stroke risk.

Brain aneurysms are another key condition driving stent adoption. Flow-diverting stents are used to treat wide-necked or large aneurysms that are difficult to treat with traditional coiling techniques. These stents offer a minimally invasive solution that reduces the risk of aneurysm rupture and allows for vessel healing over time. Additionally, neurovascular stents are being used in treating vascular malformations such as arteriovenous malformations (AVMs), further expanding their applications in neurology.

What Are the Key Growth Drivers in the Neurovascular Stents Market?

The growth in the neurovascular stents market is driven by several factors. The increasing incidence of ischemic strokes and brain aneurysms, particularly among aging populations, is a primary driver of demand. Additionally, the growing preference for minimally invasive procedures is pushing the adoption of neurovascular stents, as they offer safer, faster, and more effective treatment options than traditional surgery. Technological innovations in stent design, such as flow-diversion technology and bioresorbable materials, are also fueling market growth by improving the safety and efficacy of these devices.

The rising awareness of stroke prevention and the benefits of early intervention, along with government initiatives to reduce stroke-related mortality, are further boosting the market. Moreover, advances in medical imaging and real-time navigation technologies are making neurovascular stent procedures more precise, enhancing patient outcomes. Expanding healthcare infrastructure in developing regions is also contributing to market growth by increasing access to advanced neurovascular treatments.

SCOPE OF STUDY:

The report analyzes the Neurovascular Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Carotid Artery Stents, Intracranial Stents); End-Use (Hospitals, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Abbott Laboratories
  • ACANDIS GmbH
  • Blockade Medical LLC
  • Cordis Corporation
  • InspireMD, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • STI Laser Industries, Ltd.
  • Stryker Corporation
  • Terumo Medical Corporation
  • W. L. Gore & Associates

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Neurovascular Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Stroke and Aneurysms Drives Demand for Neurovascular Stents in Minimally Invasive Treatments
    • Advancements in Stent Technology Propel Growth in Neurovascular Stents for Aneurysm Coiling and Clot Removal
    • Increasing Adoption of Flow Diversion Stents Expands Market for Aneurysm Management in Interventional Neurology
    • Growing Preference for Minimally Invasive Procedures Strengthens Demand for Neurovascular Stents in Stroke Treatment
    • Technological Innovations in Retrievable and Fully-Deployable Stents Accelerate Adoption in Complex Neurovascular Cases
    • Rising Use of Drug-Eluting Stents for Neurovascular Applications Expands Opportunities for Improved Patient Outcomes
    • Expansion of Stent-Assisted Coiling in Aneurysm Procedures Generates New Demand for Hybrid Neurovascular Devices
    • Increasing Focus on Patient-Specific Stents and Customized Solutions Drives Growth in Personalized Neurovascular Interventions
    • Growing Adoption of Bioabsorbable Stents Strengthens Market for Next-Generation Neurovascular Devices
    • Rising Prevalence of Cerebral Aneurysms in Aging Populations Expands Market for Neurovascular Stents in Elderly Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurovascular Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Carotid Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intracranial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intracranial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intracranial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Neurovascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Europe 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Rest of Europe 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Asia-Pacific 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Asia-Pacific 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of World 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of World 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION